09.45:- Panel Discussion: - CEO Roundtable:-Strategic leadership in Indian Pharma sector
- What leadership competencies are most critical for success in pharmaceutical organizations?
- How strong are current pharma leaders in the competencies most critical to success?
- How to improve employee leadership capabilities within your organization
11.30:- Current trends, Opportunities and way forward of the pharmaceutical industry
- Looking at the status of the pharmaceutical industry and how economic factors have played a role
- A prospective analysis of current trends in Indian Pharma sector
- Opportunities for growth in Domestic Pharma Sector
- Challenges and Way Forward for Pharmaceutical Industry
12.15:- Emerging role of IT in Indian pharmaceutical industry and its implications
14.00:- Panel Discussion: - Regulatory issues affecting the pharmaceutical market
- What were the results in 2011 and what can market players expect from regulatory bodies in the near future?
- What are the government's current priorities and plans to develop the pharmaceutical sector in India
- What are the recent and planned changes to the industry's regulatory policy
15.00:- Continuous Manufacturing in Pharma
- What are the benefits of continuous processes and the importance of investing
- What facility designs and upgrades are needed for the successful deployment of continuous manufacturing?
09.45:- Panel Discussion:-Building Pharma Brands : Challenges & Oppourtunities of Mid-Sized Companies.
- Branding will help you differentiate your drug even if there are other drugs in the market that share the same ingredients and formulation as yours.
- Strongly branded prescription drugs can more easily make the transition in to the Over-The-Counter arena where customers have the decision making in their hands and not the doctors.
- Branding helps prolong the commmercial life of the drug after patent expiry.
- The global meltdown could negatively impact Indian pharma exports but good relationships with the target audience help to sustain longer in the markets
- Marketing of pharma products calls for a strong field-force network complimented with a robust supply-chain.
11.30:- The Future of the Biologics Industry and Biomanufacturing
- The importance of efficient and sustainable biomanufacturing processes
- Evaluating the role of single use equipment in this and the potential savings
- Key trends in biomanufacturing growth – where next?
12.15:- Collaborative Drug Discovery &new; initiatives to update and expand methodologies to monitor drug safety
- Drive innovation and drug development through collaborations with academia and adopting alternative models
14.00:-Building a public-private partnership
- Partner with government to increase access to your medicines and support the government's interests in further developments
- How technology transfer can be an innovative strategy for a long-lasting collaboration that will ensure a sustainable supply of your products
- Case study of creating a PPP in order to understand possible advantages and disadvantages
14.45:- Cost-effective packaging solutions
- Identifying the most cost-effective packaging and monitoring solutions
- Analyzing the challenges and solutions for packaging material reuse
- Establishing an environment-friendly plan for toxic products packaging
15.00:-Social Media in Pharma
- Challenges and opportunities social media presents for the pharmaceutical industry
- What are some industry best practices?
- Leveraging Social Media Platforms to Enhance Patient Relationships
- The Risks and Rewards of Involving the e-Patient in Clinical Trial Research
16.00:-End of Day 2
